Posted in

Negative-Strand RNA Transcription: Molecular Mechanisms of mRNA Synthesis

Negative-Strand RNA Transcription: Molecular Mechanisms of mRNA SynthesisI. Genomic Constraints and Primer Requirements

Negative-sense RNA viruses (-ssRNA) possess genomes that are functionally inert upon host cell entry:

  • Non-translatable Sequence: The genome is complementary to mRNA, preventing direct ribosome binding
  • RdRp Dependency: Virion-packaged RNA-dependent RNA polymerase (RdRp) is essential for primary transcription
    Negative-Strand RNA Transcription: Molecular Mechanisms of mRNA Synthesis
  • Structural Protection: Genomic RNA is coated by nucleoprotein (NP) forming ribonucleoprotein (RNP) complexes, preventing immune recognition

(Fig. 1: Virion Entry and RNP Release)
Description: Viral envelope fusion (left) releasing RNP complexes (NP-coated RNA in purple) into cytoplasm. RdRp (yellow) bound to RNP complex.


II. Transcription Initiation: A Three-Step Mechanism

Step 1: Promoter Binding

RdRp recognizes conserved leader sequences at the 3′-end of the genome:

  • Cis-acting elements: PAN (promoter-associated nucleotide) motifs in influenza viruses
  • Conformational activation: RdRp unwinds RNA-NP interactions to access template

Step 2: Cap-Snatching

Unique to -ssRNA viruses, RdRp “steals” host mRNA caps:

  • Endonuclease activity: Cleaves 5′-cap structures (m⁷GpppN) from host mRNAs
  • Cap Grafting: Transfers caps to nascent viral transcripts via phosphodiester bonds

(Fig. 2: Cap-Snatching Mechanism)
Description: Host mRNA (blue) with m⁷G cap (gold). Viral endonuclease (red) cleaving cap. RdRp (yellow) attaching cap to viral transcript (purple).

Step 3: Processive Transcription

RdRp synthesizes monocistronic mRNAs:

  • Sequential gene expression: RdRp initiates at each gene-start (GS) signal
  • Attenuation at gene-end (GE) signals: Polyadenylation via RdRp “stuttering” on uridine tracts (UUUUU)

III. Transcriptional Regulation: Stop-Restart Dynamics

Signal Type Sequence Motif RdRp Action
Gene Start (GS) UCCU/ACNU (viral-specific) Initiates mRNA synthesis with capped 5′-end
Gene End (GE) PolyU tract Stutters to add poly(A) tail (50-200 adenines)
Intergenic Region Non-transcribed spacer Detaches/reassembles for next gene transcription

Critical Features:

  • Polycistronic avoidance: Prevents translation of multi-gene mRNAs
  • Transcriptional gradient: Proximal genes (NP, L) express >100x higher than distal genes

(Fig. 3: Stop-Restart Transcription)
Description: RdRp (yellow) synthesizing mRNA-1 (green) until GE signal (red). Reinitiation at GS signal of mRNA-2 (blue) downstream.


IV. Viral Family-Specific Variations

A. Cytoplasmic Transcription

  • Rhabdoviridae (Rabies): Single RdRp entry site with sequential GS-GE processing
  • Filoviridae (Ebola): Transcriptional “sliding” across overlapping genes

B. Nuclear Transcription

  • Orthomyxoviridae (Influenza): Uses host nuclear RNA polymerase II for cap-snatching
    Negative-Strand RNA Transcription: Molecular Mechanisms of mRNA Synthesis
  • Arenaviridae (Lassa): Ambisense coding requires both genomic and antigenomic transcription

V. Clinical Implications of Transcriptional Control

A. Antiviral Targeting

  • Cap-snatching inhibitors: Baloxavir blocks influenza endonuclease
  • Polymerase inhibitors: Favipiravir induces lethal mutagenesis in RdRp

B. Vaccine Design

  • Attenuation strategies: GE signal mutations reduce virulence (e.g., RSV vaccine candidates)
  • mRNA vaccines: Synthetic -ssRNA transcripts mimicking viral mRNAs
    Negative-Strand RNA Transcription: Molecular Mechanisms of mRNA Synthesis

VI. Unresolved Mechanistic Questions

  1. How do RdRp complexes maintain processivity across >10,000 nt genomes?
  2. What triggers the switch from transcription to replication?
  3. Why do segmented viruses (Orthomyxoviridae) exhibit nuclear dependency?

“Negative-strand RNA viruses exemplify evolutionary ingenuity: converting genomically inert RNA into therapeutic targets through hijacked transcriptional machinery.”
— Nature Microbiology, 2025


Data sourced from publicly available references. For collaboration inquiries, contact: chuanchuan810@gmail.com.

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注